These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 38276546)

  • 1. The Role of Intestinal Microbiota and Diet as Modulating Factors in the Course of Alzheimer's and Parkinson's Diseases.
    Czarnik W; Fularski P; Gajewska A; Jakubowska P; Uszok Z; Młynarska E; Rysz J; Franczyk B
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38276546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Gut Microbiota Through Dietary Intervention in Neuroinflammation and Alzheimer's and Parkinson's Diseases.
    Ayten Ş; Bilici S
    Curr Nutr Rep; 2024 Jun; 13(2):82-96. PubMed ID: 38652236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
    Zheng Y; Bonfili L; Wei T; Eleuteri AM
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy.
    Nohesara S; Abdolmaleky HM; Thiagalingam S; Zhou JR
    Epigenomics; 2024 Jan; 16(1):57-77. PubMed ID: 38088063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Relationship Between the Gut Microbiome and Neurodegenerative Diseases.
    Zhu X; Li B; Lou P; Dai T; Chen Y; Zhuge A; Yuan Y; Li L
    Neurosci Bull; 2021 Oct; 37(10):1510-1522. PubMed ID: 34216356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gut-Brain Axis in Alzheimer's and Parkinson's Diseases: The Catalytic Role of Mitochondria.
    Candeias E; Pereira-Santos AR; Empadinhas N; Cardoso SM; Esteves ARF
    J Alzheimers Dis; 2024; 100(2):413-429. PubMed ID: 38875045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
    Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
    Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
    Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
    Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.
    Varesi A; Campagnoli LIM; Fahmideh F; Pierella E; Romeo M; Ricevuti G; Nicoletta M; Chirumbolo S; Pascale A
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The connection between gut microbiota and its metabolites with neurodegenerative diseases in humans.
    Fabi JP
    Metab Brain Dis; 2024 Jun; 39(5):967-984. PubMed ID: 38848023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in the application of fecal microbiota transplantation for the treatment of nervous system diseases].
    Ma X; Zhang L; Gao J; Chen F
    Sheng Wu Gong Cheng Xue Bao; 2024 May; 40(5):1293-1308. PubMed ID: 38783798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
    Goyal D; Ali SA; Singh RK
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases.
    Gubert C; Kong G; Renoir T; Hannan AJ
    Neurobiol Dis; 2020 Feb; 134():104621. PubMed ID: 31628992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral and intestinal dysbiosis in Parkinson's disease.
    Berthouzoz E; Lazarevic V; Zekeridou A; Castro M; Debove I; Aybek S; Schrenzel J; Burkhard PR; Fleury V
    Rev Neurol (Paris); 2023 Nov; 179(9):937-946. PubMed ID: 36934020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives.
    Li Y; Wang R; Li Q; Wang YJ; Guo J
    J Alzheimers Dis; 2021; 83(3):963-976. PubMed ID: 34366348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology.
    Rutsch A; Kantsjö JB; Ronchi F
    Front Immunol; 2020; 11():604179. PubMed ID: 33362788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review.
    Matheson JT; Holsinger RMD
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the Gut Microbial Metabolome Really Matter? The Connection between GUT Metabolome and Neurological Disorders.
    Marć MA; Jastrząb R; Mytych J
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.